Nordea Investment Management AB Boosts Stock Holdings in Solventum Co. (NYSE:SOLV)

Nordea Investment Management AB boosted its position in Solventum Co. (NYSE:SOLV) by 189.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 659,887 shares of the company’s stock after buying an additional 431,986 shares during the quarter. Nordea Investment Management AB owned approximately 0.38% of Solventum worth $43,902,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of SOLV. Copeland Capital Management LLC bought a new position in shares of Solventum during the 3rd quarter worth $26,000. Modus Advisors LLC bought a new position in Solventum during the fourth quarter worth about $25,000. Mather Group LLC. purchased a new position in shares of Solventum in the third quarter worth about $27,000. Hollencrest Capital Management bought a new stake in shares of Solventum in the second quarter valued at approximately $25,000. Finally, True Wealth Design LLC lifted its stake in shares of Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after buying an additional 471 shares in the last quarter.

Analysts Set New Price Targets

A number of brokerages have issued reports on SOLV. Morgan Stanley boosted their target price on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Piper Sandler increased their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Wolfe Research started coverage on Solventum in a report on Thursday, September 26th. They set a “peer perform” rating for the company. Stifel Nicolaus initiated coverage on shares of Solventum in a research report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price objective for the company. Finally, Mizuho assumed coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective for the company. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Solventum currently has an average rating of “Hold” and an average price target of $68.29.

Solventum Price Performance

Shares of Solventum stock opened at $69.46 on Wednesday. The company has a 50 day simple moving average of $69.59 and a two-hundred day simple moving average of $64.63. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.